...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Synthesis, antitumor evaluation and molecular docking studies of [1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine derivatives
【24h】

Synthesis, antitumor evaluation and molecular docking studies of [1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine derivatives

机译:[1,2,4]三唑并[4,3-b] [1,2,4,5]四嗪衍生物的合成,抗肿瘤评价和分子对接研究

获取原文
获取原文并翻译 | 示例
           

摘要

A series of [1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine derivatives have been synthesized and evaluated for their antitumor activities. These compounds exhibited potent antiproliferative activities against MCF-7, Bewo and HL-60 cells and c-Met kinase inhibitory activities. Three compounds were highly effective against MCF-7, Bewo and HL-60 cells with IC50 values in 1.09-2.24 mu M. Molecular docking was further performed to study the inhibitor-c-Met kinase interactions, and the results show that compound 4j was potently bound to the c-Met kinase with three hydrogen bonds. The further research on acute toxicity and in vivo antitumor activity of compound 4j to ICR (Institute of Cancer Research) mice were carried out, and found 4j with a certain toxicity but good efficacy in vivo. Based on the preliminary results, it is deduced that compound 4j with potent c-Met kinase inhibitory activity may be a potential anticancer agent. (C) 2016 Elsevier Ltd. All rights reserved.
机译:合成了一系列[1,2,4]三唑并[4,3-b] [1,2,4,5]四嗪衍生物并评估了其抗肿瘤活性。这些化合物对MCF-7,Bewo和HL-60细胞显示出有效的抗增殖活性,并具有c-Met激酶抑制活性。三种化合物对MCF-7,Bewo和HL-60细胞具有很高的效果,IC50值在1.09-2.24μM之间。进一步进行了分子对接研究抑制剂-c-Met激酶的相互作用,结果表明化合物4j为通过三个氢键与c-Met激酶有效结合。对化合物4j对ICR(Institute of Cancer Research,小鼠)的急性毒性和体内抗肿瘤活性进行了进一步研究,发现4j具有一定的毒性,但在体内具有良好的疗效。根据初步结果,推断具有有效c-Met激酶抑制活性的化合物4j可能是潜在的抗癌药。 (C)2016 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号